Seeing is Believing: The Role of Artificial Intelligence in Ophthalmology
Artifical intelligence use is growing across medicine. From imaging to chatbots, ophthalmology is the center of one of these transformations.
Source: hcplive.com
📰 Jonathan Jonisch News
Jonathan Jonisch News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jonathan Jonisch. Real-time updates on events, politics, business and more.
High Dose Aflibercept as Emerging Therapy for Retinal Diseases
Experts discuss the recent PULSAR and PHOTON studies with high dose aflibercept (8mg) and how they educate patients about this treatment approach.
Ehsan Rahimy Veeral Sheth Jonathan Jonisch Anti Vegf Age Related Macular Degeneration Macular Degeneration
Source: hcplive.com
Step Therapy for Patients With DME
Experts discuss insurer mandated step therapy and how to navigate treatment options for patients with diabetic macular edema (DME).
United States Jonathan Jonisch Veeral Sheth Ehsan Rahimy Bali Khan American Academy Of Ophthalmology
Source: hcplive.com
Efficacy of Faricimab in Clinical Trails
Experts discuss clinical trials on the efficacy of faricimab and how they utilize this therapy in their practice.
Source: hcplive.com
Key Findings of Protocol T Study
Experts discuss the results of Protocol T study comparing anti-vascular endothelial growth factor (Anti-VEGF) agents for the treatment of diabetic macular edema (DME).
Source: hcplive.com
Key Findings of DRCR Protocol AC Study
Experts discuss the recent DRCR Protocol AC study comparing aflibercept monotherapy vs bevacizumab first therapy for patients with diabetic macular edema (DME).
Veeral Sheth Jonathan Jonisch Ehsan Rahimy New England Journal Diabetic Macular Edema Age Related Macular Degeneration
Source: hcplive.com